Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway
Theranostics. 2025 Mar 31;15(11):4989-5006. doi: 10.7150/thno.107367. eCollection 2025. ABSTRACT Background: Diabetic cardiomyopathy (DCM), a prevalent complication of diabetes, is a major cause of heart failure …